Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Debt Ratio (2016 - 2025)

Fortress Biotech has reported Debt Ratio over the past 13 years, most recently at 0.28 for Q4 2025.

  • Quarterly results put Debt Ratio at 0.28 for Q4 2025, down 29.71% from a year ago — trailing twelve months through Dec 2025 was 0.28 (down 29.71% YoY), and the annual figure for FY2025 was 0.28, down 29.71%.
  • Debt Ratio for Q4 2025 was 0.28 at Fortress Biotech, up from 0.26 in the prior quarter.
  • Over the last five years, Debt Ratio for FBIO hit a ceiling of 0.46 in Q2 2024 and a floor of 0.1 in Q3 2021.
  • Median Debt Ratio over the past 5 years was 0.29 (2023), compared with a mean of 0.28.
  • Biggest five-year swings in Debt Ratio: plummeted 57.13% in 2021 and later soared 187.83% in 2022.
  • Fortress Biotech's Debt Ratio stood at 0.11 in 2021, then soared by 187.83% to 0.31 in 2022, then increased by 16.55% to 0.36 in 2023, then rose by 10.63% to 0.4 in 2024, then dropped by 29.71% to 0.28 in 2025.
  • The last three reported values for Debt Ratio were 0.28 (Q4 2025), 0.26 (Q3 2025), and 0.31 (Q2 2025) per Business Quant data.